BIOMAT Database Logo BIOMAT Database Logo

A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia. 1993

D J Hellerstein, and P Yanowitch, and J Rosenthal, and L W Samstag, and M Maurer, and K Kasch, and L Burrows, and M Poster, and M Cantillon, and A Winston
Psychiatric Outpatient Service, Beth Israel Medical Center, New York, NY 10003.

OBJECTIVE The purpose of this study was to assess the efficacy of fluoxetine, a selective serotonergic antidepressant, in the treatment of dysthymia. METHODS Thirty-five patients who met criteria for dysthymia, but not major depression, began randomized, double-blind 8-week trials of fluoxetine or placebo. RESULTS Of 32 patients who completed the study, 10 (62.5%) of the 16 patients given fluoxetine and three (18.8%) of the 16 given placebo responded to treatment. Response was defined as 1) 50% or greater decrease in Hamilton Rating Scale for Depression score and 2) a score of 1 or 2 on the Clinical Global Impression (CGI) improvement subscale. Fluoxetine subjects showed significantly greater improvement at week 8 than placebo subjects on the Hamilton depression and CGI scales, but not on the Hopkins Symptom Check-list (58-item) or the Cornell Dysthymia Rating Scale. CONCLUSIONS When compared to placebo, fluoxetine showed short-term effectiveness in treating dysthymic symptoms.

UI MeSH Term Description Entries
D008297 Male Males
D010555 Personality Inventory Check list, usually to be filled out by a person about himself, consisting of many statements about personal characteristics which the subject checks. Edwards Personal Preference Schedule,Myers-Briggs Type Indicator,Indicator, Myers-Briggs Type,Inventories, Personality,Inventory, Personality,Myers Briggs Type Indicator,Personality Inventories
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D005473 Fluoxetine The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants. Fluoxetin,Fluoxetine Hydrochloride,Lilly-110140,N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine,Prozac,Sarafem,Lilly 110140,Lilly110140
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D J Hellerstein, and P Yanowitch, and J Rosenthal, and L W Samstag, and M Maurer, and K Kasch, and L Burrows, and M Poster, and M Cantillon, and A Winston
Moclobemide versus fluoxetine for double depression: a randomized double-blind study.
January 1996, Journal of psychiatric research,
D J Hellerstein, and P Yanowitch, and J Rosenthal, and L W Samstag, and M Maurer, and K Kasch, and L Burrows, and M Poster, and M Cantillon, and A Winston
Isotretinoin versus placebo in the treatment of cystic acne. A randomized double-blind study.
April 1982, Journal of the American Academy of Dermatology,
D J Hellerstein, and P Yanowitch, and J Rosenthal, and L W Samstag, and M Maurer, and K Kasch, and L Burrows, and M Poster, and M Cantillon, and A Winston
Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission: a double-blind, comparative study.
February 1998, Journal of affective disorders,
D J Hellerstein, and P Yanowitch, and J Rosenthal, and L W Samstag, and M Maurer, and K Kasch, and L Burrows, and M Poster, and M Cantillon, and A Winston
A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia.
February 2002, The American journal of medicine,
D J Hellerstein, and P Yanowitch, and J Rosenthal, and L W Samstag, and M Maurer, and K Kasch, and L Burrows, and M Poster, and M Cantillon, and A Winston
Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy.
January 1991, Pharmacopsychiatry,
D J Hellerstein, and P Yanowitch, and J Rosenthal, and L W Samstag, and M Maurer, and K Kasch, and L Burrows, and M Poster, and M Cantillon, and A Winston
Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study.
September 1994, Journal of the American Academy of Child and Adolescent Psychiatry,
D J Hellerstein, and P Yanowitch, and J Rosenthal, and L W Samstag, and M Maurer, and K Kasch, and L Burrows, and M Poster, and M Cantillon, and A Winston
Saffron for treatment of fluoxetine-induced sexual dysfunction in women: randomized double-blind placebo-controlled study.
January 2013, Human psychopharmacology,
D J Hellerstein, and P Yanowitch, and J Rosenthal, and L W Samstag, and M Maurer, and K Kasch, and L Burrows, and M Poster, and M Cantillon, and A Winston
Fluoxetine treatment of acral lick dermatitis in dogs: a placebo-controlled randomized double blind trial.
January 1998, Depression and anxiety,
D J Hellerstein, and P Yanowitch, and J Rosenthal, and L W Samstag, and M Maurer, and K Kasch, and L Burrows, and M Poster, and M Cantillon, and A Winston
Tadalafil and fluoxetine in premature ejaculation: prospective, randomized, double-blind, placebo-controlled study.
January 2008, Urologia internationalis,
D J Hellerstein, and P Yanowitch, and J Rosenthal, and L W Samstag, and M Maurer, and K Kasch, and L Burrows, and M Poster, and M Cantillon, and A Winston
S-fluoxetine in the prophylaxis of migraine: a phase II double-blind randomized placebo-controlled study.
June 1998, Cephalalgia : an international journal of headache,
Copied contents to your clipboard!